What is the 2024 FDA user fee for a standard 510k submission?

Navigating FDA 510(k) User Fees: A Comprehensive Guide to Payment, Qualification, and Submission When budgeting for a new Class II medical device submission, such as a next-generation infusion pump or a novel diagnostic assay, accurately accounting for the FDA user fee is a critical project management step. Under the Medical Device User Fee Amendments (MDUFA), most premarket submissions, including 510(k)s, require the payment of a substantial fee to support the FDA's review activities. While sponsors often focus on the specific dollar amount, the surrounding administrative process is equally critical. A failure to navigate the fee qualification, payment, and documentation requirements correctly can lead to a Refuse-to-Accept (RTA) hold, delaying the start of the substantive review by weeks or even months. This guide provides a detailed overview of the procedural and strategic considerations for managing the 510(k) user fee requirement, helping sponsors avoid common pitfalls and ensure a smooth submission process. ### Key Points * **Official Fee Schedule is Paramount:** FDA user fees are updated annually for each U.S. government fiscal year (which begins October 1). Sponsors must **always** consult the official FDA website for the current fee schedule before making a payment. Do not rely on past figures or third-party sources. * **Small Business Qualification is a Separate Process:** To qualify for a significantly reduced fee, an organization must apply to be recognized as a "small business" by the FDA. This is a separate application that must be submitted and approved **before** the 510(k) is filed. * **Payment Must Precede Submission:** The full user fee must be paid and processed *before* submitting the 510(k) to the FDA. Submitting a 510(k) without proof of payment is a common reason for an immediate RTA hold. * **Documentation is Mandatory:** Every submission requiring a fee must include a completed User Fee Cover Sheet (Form FDA 3601). This form links your payment to your specific 510(k) submission. * **Consistency Prevents Delays:** The organization's name on the fee payment, the User Fee Cover Sheet, and the 510(k) submission itself must be identical. Discrepancies can trigger administrative holds while the FDA resolves the inconsistency. * **Proactive Planning is Essential:** The user fee process, particularly the small business qualification, should be initiated months in advance of the planned 510(k) submission date to avoid preventable delays. ### Understanding FDA User Fees (MDUFA) The authority for the FDA to collect user fees comes from the Medical Device User Fee Amendments (MDUFA). First enacted in 2002 and reauthorized by Congress every five years, MDUFA is intended to provide the FDA with a predictable stream of funding to expedite the review of medical devices. These funds support the hiring of review staff and the modernization of the review process. Because the fees are set annually based on inflation and other factors, the specific dollar amount for a standard 510(k) changes each fiscal year. For the most current and official fee information, sponsors must consult the FDA's dedicated user fee webpage: **https://www.fda.gov/industry/fda-user-fees**. ### Qualifying for Small Business Fee Reductions One of the most significant opportunities for cost savings is qualifying for the small business fee. This can reduce the 510(k) user fee by as much as 75%. However, obtaining this status requires a formal, proactive application process. #### **General Eligibility Criteria** An organization, including its affiliates, must meet the FDA's definition of a small business, which is generally based on gross receipts or sales. This definition is specified by the FDA and requires certification. It is not sufficient to simply self-identify as a small business. #### **The Small Business Determination (SBD) Application Process** 1. **Locate the Correct Form:** The application is made using Form FDA 3602, "FY [Year] MDUFA Small Business Qualification and Certification." Sponsors must ensure they are using the form for the correct fiscal year. 2. **Gather Financial Documentation:** The application typically requires a copy of the organization's (and its affiliates') most recent U.S. federal income tax return. The FDA uses this to verify that the gross receipts or sales are below the established threshold. 3. **Submit the Application:** The completed form and supporting documents are submitted to the FDA's Center for Devices and Radiological Health (CDRH). The submission process is electronic. 4. **Receive an SBD Number:** If the application is approved, the FDA will issue a Small Business Determination (SBD) number. This number is valid for the remainder of the fiscal year and is the official proof of qualification. #### **Critical Timeline Considerations** The SBD approval process is not instantaneous. FDA guidance suggests submitting the application **at least 60 days before** the planned 510(k) submission. This buffer accounts for FDA processing time and allows sponsors to resolve any potential questions or issues with their application without delaying their 510(k) filing. A 510(k) submitted with a small business fee payment but *without* an approved SBD number will be placed on hold. ### The Critical Timing of Payment and Submission The FDA's process is unambiguous: the 510(k) user fee must be paid in full before the submission is sent to the agency. #### **Procedural Consequences of Improper Timing** If a 510(k) submission arrives at the FDA and the agency cannot verify that the fee has been paid, it will be placed on an RTA hold. The 15-day clock for the FDA's acceptance review will not start. The submission remains on hold until the sponsor provides proof of payment, at which point the acceptance review clock can begin. This simple administrative error can easily add weeks of delay to the start of the substantive review. #### **Recommended Workflow for Payment and Submission** 1. **Confirm the Correct Fee Amount:** Verify the fee (either standard or small business) using the official FDA MDUFA fee schedule for the current fiscal year. 2. **Make the Payment:** Use the FDA's online payment portal to submit the user fee. Upon successful payment, you will receive a Payment Confirmation Number (PCN). 3. **Complete the User Fee Cover Sheet:** Fill out Form FDA 3601, ensuring all information is accurate. Critically, you must enter the PCN you received in the previous step. 4. **Assemble the 510(k) Submission:** Place the completed User Fee Cover Sheet in the administrative section of your 510(k) eCopy (e.g., in section 1 of the electronic submission). 5. **Submit the 510(k) Package:** With proof of payment included, you can now submit your 510(k) to the FDA. ### Common Pitfalls and How to Avoid an RTA Hold Beyond paying late, several other administrative errors related to user fees can trigger an RTA hold. Proactive planning and careful attention to detail are the best ways to mitigate these risks. * **Pitfall 1: Paying the Incorrect Fee Amount** * **Scenario:** A company plans a submission in late September but experiences a slight delay, pushing the submission into early October. They pay the fee from the previous fiscal year, which is now incorrect. * **Mitigation Strategy:** Always double-check the effective dates for the fee schedule on the FDA's website. If submitting near the fiscal year transition (October 1), be absolutely certain you are paying the correct amount for the date of submission. * **Pitfall 2: Discrepancies in Company Names** * **Scenario:** A startup, "Innovate MedTech, Inc.," has its fee paid by its parent investment firm, "Venture Capital Partners, LLC." The 510(k) is submitted under the Innovate MedTech name, but the payment is from Venture Capital Partners. The FDA's system cannot automatically link the payment to the submission. * **Mitigation Strategy:** The legal entity name of the sponsor listed on the 510(k) cover letter and other forms **must** match the name of the entity paying the fee. If a different entity must pay, ensure the payment documentation clearly references the 510(k) sponsor's name and the purpose of the payment. * **Pitfall 3: Missing or Incorrect Payment Confirmation Number (PCN)** * **Scenario:** The sponsor pays the fee on time but either forgets to include the PCN on Form FDA 3601 or makes a typo when entering it. * **Mitigation Strategy:** Treat the PCN as a critical piece of data. Copy and paste it directly from the payment portal confirmation into your records and onto the cover sheet. Have a second person review the form for accuracy before finalizing the submission package. * **Pitfall 4: Submitting Before SBD Approval is Final** * **Scenario:** A company applies for small business status and, assuming it will be approved, pays the reduced fee and submits its 510(k) a week later. The SBD application is still pending review. * **Mitigation Strategy:** Do not submit the 510(k) until you have the official SBD approval number in hand from the FDA. Build this waiting period into your project timeline from the very beginning. ### Strategic Considerations and the Role of Q-Submission While user fee logistics are not a topic for a Q-Submission, the overall regulatory strategy discussed in a Q-Sub has major budgetary implications. Early engagement with the FDA can clarify the most appropriate regulatory pathway (e.g., 510(k) vs. De Novo), which directly impacts the user fee required. More importantly, a Q-Submission can provide clarity on the testing and data requirements for a submission. Understanding whether the FDA expects extensive bench testing, animal studies, or even clinical data has a far greater impact on the overall project budget than the user fee itself. By clarifying these expectations early, a sponsor can develop a more accurate and comprehensive budget, of which the user fee is just one component. ### Key FDA References - FDA Guidance: general 510(k) Program guidance on evaluating substantial equivalence. - FDA Guidance: Q-Submission Program – process for requesting feedback and meetings for medical device submissions. - 21 CFR Part 807, Subpart E – Premarket Notification Procedures (overall framework for 510(k) submissions). ## How tools like Cruxi can help Managing the administrative details of a 510(k) submission is a complex task where small errors can lead to significant delays. Regulatory information management platforms like Cruxi can help teams maintain consistency and control over their submission documentation. By providing a centralized workspace to manage forms, track key dates (like SBD application deadlines), and ensure consistent company information across all documents, these tools can help mitigate the risk of common RTA triggers related to user fees and other administrative requirements. *** *This article is for general educational purposes only and is not legal, medical, or regulatory advice. For device-specific questions, sponsors should consult qualified experts and consider engaging FDA via the Q-Submission program.*